… to severe acute respiratory syndrome coronavirus 2 is crucial to understanding … coronavirus
2 and relate this knowledge to the COVID-19 vaccines currently in phase 3 clinical trials…

… Although Pennsylvania-based company Inovio has not yet entered officially Phase 3
trials their candidate is the most advanced SARS-CoV-2 DNA vaccine so far. Inovio …

… are already available for several vaccine candidates, and many have moved into phase
III trials. The data available so far suggest that effective and safe vaccines might become …

… SARS-CoV-2. We present the interim efficacy and safety results of a phase 3 clinical trial of
… interim efficacy and safety results of phase 3 trials: ChAdOx1 nCoV-19 vaccine (University of …

… Considering the safety and efficacy profile in the phase 1/2 study, we conducted a phase
3 study to evaluate efficacy, safety, and immunogenicity of a 2 mg dose of ZyCoV-D vaccine …

… whether SARS-CoV-2 vaccine with EUA or in phase III trials … , prior to phase III trials, meet
the criteria for an ideal SARS-CoV-2 … from phase III trials and recommendations for phase IV …

… In this Article, we report interim results from a phase 3 case-driven efficacy study, including
a subset analysis of efficacy against newly identified SARS-CoV-2 variants of concern (VOCs) …

… , randomised, double-blind, placebo-controlled clinical trial in … In this phase 3 trial, we
demonstrated for the first time the safety and efficacy of a COVID-19 vaccine based on a SARS-CoV…

… The primary and secondary aims of the study include the evaluation of safety parameters …
against SARS-CoV-2 after immunization, respectively. This trial is registered at clinicaltrials.gov …

… SARS-CoV-2 vaccine in preventing COVID-19 including safety and immunogenicity data
based on the phase III trial collected during a 3-… This data set and trial results form the basis of …